NITRIC OXIDE-BIOLOGY AND CHEMISTRY is a premier journal dedicated to the exploration of the multifaceted roles of nitric oxide in biological systems, contributing significantly to the fields of biochemistry, physiology, and cancer research. Published by Academic Press Inc, Elsevier Science, the journal boasts a solid reputation, evidenced by its 2023 quartile rankings, including Q2 in Biochemistry, Clinical Biochemistry, and Physiology, as well as Q3 in Cancer Research. Researchers and professionals seeking to stay abreast of the latest developments can benefit from its rigorous peer-reviewed articles and insightful reviews, which span a convergence of studies from 1997 to 2024. Although not an open-access journal, it provides ample opportunities for institutional subscriptions and ensures a global reach, facilitating the dissemination of vital scientific knowledge. The journal's impact is further underscored by its impressive Scopus rankings, reaffirming its importance as a key resource for scholars intent on advancing their understanding of nitric oxide's biological significance.

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS is a prestigious journal published by Elsevier, dedicated to advancing the fields of biochemistry, biophysics, and cell biology. Established in 1967, this journal is committed to disseminating high-quality research that unveils the molecular mechanisms of bioenergetics, encompassing a wide range of topics from mitochondrial function to energy metabolism. With an exceptional impact factor and a current ranking in the Q1 quartile across multiple categories—specifically ranked #13 in Biophysics and featuring strong positions in Biochemistry and Cell Biology—this journal is recognized for its influential contributions to the scientific community. Scholars, researchers, and students globally benefit from its rigorous peer-review process and access options, although it is not currently open access. By providing a platform for innovative research, BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS plays a critical role in fostering scientific advancement and collaboration among professionals in the field.

Cell Stress is a prestigious, peer-reviewed open access journal dedicated to advancing research in the fields of biochemistry, genetics, molecular biology, cancer research, and physiology. Published by SHARED SCIENCE PUBLISHERS OG in Austria, this journal has rapidly established itself since its inception in 2017, achieving Q1 status in multiple categories, indicative of its high impact and quality. With an impressive Scopus ranking—holding a top percentile position in its respective fields—Cell Stress aims to foster interdisciplinary collaboration and disseminate cutting-edge findings that enhance our understanding of cellular stress mechanisms and their implications in health and disease. The journal's commitment to open access since its launch ensures that critical research is accessible to a global audience, thereby facilitating the exchange of knowledge among researchers, professionals, and students alike. Address your submissions or inquiries to AM BLUMENHAG 25-4, Graz 8010, Austria, and contribute to this dynamic platform that is shaping the future of molecular medicine.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.